-
31.发明授权Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer 有权核苷酸和氨基酸序列，以及其用于诊断前列腺癌的测定和方法公开(公告)号：US07368548B2
公开(公告)日：2008-05-06
申请号：US11043806
申请日：2005-01-27
申请人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotem Sorek , Michal Ayalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
发明人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotem Sorek , Michal Ayalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
CPC分类号： C07K14/705 , C07K14/47 , C07K14/82 , C07K16/3069 , C12Q1/6886 , C12Q2600/112 , C12Q2600/158 , G01N33/57434
摘要： Novel markers for prostate cancer that are both sensitive and accurate. Furthermore, these markers are able to distinguish between prostate cancer and benign prostate hyperplasia (“BPH”). These markers are overexpressed in prostate cancer specifically, as opposed to normal prostate tissue and/or BPH. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of prostate cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between prostate cancer and non-cancerous states.
摘要翻译： 前列腺癌的新型标记既灵敏又准确。 此外，这些标记能够区分前列腺癌和良性前列腺增生（“BPH”）。 与正常的前列腺组织和/或BPH相反，这些标记物在前列腺癌中过度表达。 这些标记物在患者样品中单独或组合的测量提供了诊断者可以与前列腺癌的可能诊断相关的信息。 本发明的标记物单独或组合显示前列腺癌与非癌状态之间的高度差异检测。
-
公开(公告)号：US07601692B2
公开(公告)日：2009-10-13
申请号：US11471652
申请日：2006-06-21
申请人： Zurit Levine , Amir Toporik , Michal Ayalon-Soffer , Iris Hecht , Merav Beiman , Dani Eshel , Tali Handelsman , Sarah Pollock
发明人： Zurit Levine , Amir Toporik , Michal Ayalon-Soffer , Iris Hecht , Merav Beiman , Dani Eshel , Tali Handelsman , Sarah Pollock
CPC分类号： C12Q1/6883 , A61K38/00 , A61K48/00 , C07K14/523 , C12Q2600/156 , C12Q2600/158
摘要： Novel MCP-1 splice variant polypeptides and polynucleotides encoding same are provided. Also provided are pharmaceutical compositions comprising the splice variant polypeptides and polynucleotides, vectors and host cells comprising same. The compositions of the present invention are useful to treat various MCP-1 related disorders as well as for diagnosing, determining predisposition and/or prognosis of various disorders.
摘要翻译： 提供了新的MCP-1剪接变体多肽和编码它们的多核苷酸。 还提供了包含剪接变体多肽和多核苷酸，载体和包含其的宿主细胞的药物组合物。 本发明的组合物可用于治疗各种MCP-1相关疾病以及用于诊断，确定各种疾病的倾向和/或预后。
-
33.发明申请VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR AND USE THEREOF 审中-公开血管内皮生长因子（VEGF）受体及其用途的变异公开(公告)号：US20110212051A1
公开(公告)日：2011-09-01
申请号：US13037196
申请日：2011-02-28
申请人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
发明人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
IPC分类号： A61K38/19 , G01N33/53 , C07K16/28 , C07K14/535 , C07K7/06 , C07K14/715 , C07K14/47 , C07K14/735 , C07K14/475 , A61K38/17 , C07K16/24 , C07K16/22 , C12N9/66 , C07K16/40 , G01N33/573 , A61K38/48 , A61K38/18 , A61K38/08 , A61P31/00 , A61P19/08 , A61P9/00 , A61P27/02 , A61P13/12 , A61P35/00 , A61P3/04 , A61P3/10 , A61P19/10 , A61P9/10 , A61P9/04 , A61P11/00 , A61P7/02 , A61P7/04 , A61P29/00 , A61P37/06 , A61P1/18 , A61P27/14 , A61P31/10 , A61P31/20 , A61P31/22 , A61P31/18 , A61P31/14 , A61P35/04 , A61P1/16 , A61P3/00 , A61P37/02 , A61P13/00 , A61P25/00 , A61P25/28 , A61P25/16
CPC分类号： C07K14/47 , Y10S435/81
摘要： Novel polypeptides and polynucleotides encoding same are provided. Also provided methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention. Also provided are methods and kits for diagnosing, determining predisposition and/or prognosis of various disorders using as diagnostic markers the novel polypeptides and polynucleotides of the present invention.
摘要翻译： 提供了新的多肽和编码它们的多核苷酸。 还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。 还提供了用于诊断，确定各种疾病的倾向和/或预后的方法和试剂盒，其使用本发明的新型多肽和多核苷酸作为诊断标记。
-
公开(公告)号：US20100075891A1
公开(公告)日：2010-03-25
申请号：US11043770
申请日：2005-01-27
申请人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
发明人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
CPC分类号： C07K14/47 , Y10S435/81
摘要： Novel polypeptides and polynucleotides encoding same are provided. Also provided methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention. Also provided are methods and kits for diagnosing, determining predisposition and/or prognosis of various disorders using as diagnostic markers the novel polypeptides and polynucleotides of the present invention.
摘要翻译： 提供了新的多肽和编码它们的多核苷酸。 还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。 还提供了用于诊断，确定各种疾病的倾向和/或预后的方法和试剂盒，其使用本发明的新型多肽和多核苷酸作为诊断标记。
-
35.发明申请Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer 有权新型核苷酸和氨基酸序列，以及其用于诊断前列腺癌的测定和方法公开(公告)号：US20060051774A1
公开(公告)日：2006-03-09
申请号：US11043806
申请日：2005-01-27
申请人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotem Sorek , Michal Ayalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
发明人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotem Sorek , Michal Ayalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
CPC分类号： C07K14/705 , C07K14/47 , C07K14/82 , C07K16/3069 , C12Q1/6886 , C12Q2600/112 , C12Q2600/158 , G01N33/57434
摘要： Novel markers for prostate cancer that are both sensitive and accurate. Furthermore, these markers are able to distinguish between prostate cancer and benign prostate hyperplasia (“BPH”). These markers are overexpressed in prostate cancer specifically, as opposed to normal prostate tissue and/or BPH. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of prostate cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between prostate cancer and non-cancerous states.
摘要翻译： 前列腺癌的新型标记既灵敏又准确。 此外，这些标记能够区分前列腺癌和良性前列腺增生（“BPH”）。 与正常的前列腺组织和/或BPH相反，这些标记物在前列腺癌中过度表达。 这些标记物在患者样品中单独或组合的测量提供了诊断者可以与前列腺癌的可能诊断相关的信息。 本发明的标记物单独或组合显示前列腺癌与非癌状态之间的高度差异检测。
-
公开(公告)号：US07939634B2
公开(公告)日：2011-05-10
申请号：US11043770
申请日：2005-01-27
申请人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
发明人： Michal Ayalon-Soffer , Zurit Levine , Osnat Sella-Tavor , Alex Diber , Ronen Shemesh , Amir Toporik , Galit Rotman , Sergey Nemzer , Avi Rosenberg , Dvir Dahary , Assaf Wool , Gad S. Cojocaru , Pinchas Akiva , Sarah Pollock , Kinneret Savitsky , Jeanne Bernstein
CPC分类号： C07K14/47 , Y10S435/81
摘要： Novel polypeptides and polynucleotides encoding same are provided. Also provided methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention. Also provided are methods and kits for diagnosing, determining predisposition and/or prognosis of various disorders using as diagnostic markers the novel polypeptides and polynucleotides of the present invention.
摘要翻译： 提供了新的多肽和编码它们的多核苷酸。 还提供了可用于使用本发明的多肽和多核苷酸治疗各种疾病如癌症，免疫相关，血液相关和皮肤相关疾病的方法和药物组合物。 还提供了用于诊断，确定各种疾病的倾向和/或预后的方法和试剂盒，使用本发明的新型多肽和多核苷酸作为诊断标记。
-
公开(公告)号：US20070092484A1
公开(公告)日：2007-04-26
申请号：US11471652
申请日：2006-06-21
申请人： Zurit Levine , Amir Toporik , Michal Ayalon-Soffer , Iris Hecht , Merav Beiman , Dani Eshel , Tali Handelsman , Sarah Pollock
发明人： Zurit Levine , Amir Toporik , Michal Ayalon-Soffer , Iris Hecht , Merav Beiman , Dani Eshel , Tali Handelsman , Sarah Pollock
CPC分类号： C12Q1/6883 , A61K38/00 , A61K48/00 , C07K14/523 , C12Q2600/156 , C12Q2600/158
摘要： Novel MCP-1 splice variant polypeptides and polynucleotides encoding same are provided. Also provided are pharmaceutical compositions comprising the splice variant polypeptides and polynucleotides, vectors and host cells comprising same. The compositions of the present invention are useful to treat various MCP-1 related disorders as well as for diagnosing, determining predisposition and/or prognosis of various disorders.
摘要翻译： 提供了新的MCP-1剪接变体多肽和编码它们的多核苷酸。 还提供了包含剪接变体多肽和多核苷酸的药物组合物，载体和包含其的宿主细胞。 本发明的组合物可用于治疗各种MCP-1相关疾病以及用于诊断，确定各种疾病的倾向和/或预后。
-
38.发明申请Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same 审中-公开用于鉴定天然存在的反义转录物的方法和系统以及使用其的方法，试剂盒和阵列公开(公告)号：US20050009771A1
公开(公告)日：2005-01-13
申请号：US10764503
申请日：2004-01-27
申请人： Erez Levanon , Jeanne Bernstein , Sarah Pollock , Alex Diber , Zurit Levine , Sergey Nemzer , Vladimir Grebinsky , Hanqing Xie , Brian Meloon , Andrew Olson , Dvir Dahary , Yossi Cohen , Avi Shoshan , Shira Walach , Alon Wasserman , Rami Khosravi , Galit Rotman
发明人： Erez Levanon , Jeanne Bernstein , Sarah Pollock , Alex Diber , Zurit Levine , Sergey Nemzer , Vladimir Grebinsky , Hanqing Xie , Brian Meloon , Andrew Olson , Dvir Dahary , Yossi Cohen , Avi Shoshan , Shira Walach , Alon Wasserman , Rami Khosravi , Galit Rotman
CPC分类号： C12Q1/6876 , C12N15/111 , C12N2310/11 , C12N2320/11 , C12N2330/10 , C12Q2600/136 , C12Q2600/158 , G16B30/00 , Y02A50/58 , Y02A90/26
摘要： A method of identifying putative naturally occurring antisense transcripts is provided. The method is effected by (a) computationally aligning a first database including sense-oriented polynucleotide sequences with a second database including expressed polynucleotide sequences; and (b) identifying expressed polynucleotide sequences from the second database being capable of forming a duplex with at least one sense-oriented polynucleotide sequence of the first database, thereby identifying putative naturally occurring antisense transcripts. Also provided are polynucleotides and polypeptide sequences identified by the above-described methodology.
摘要翻译： 提供了鉴定推定的天然存在的反义转录物的方法。 该方法通过以下步骤来实现：（a）计算对齐包含有意向多核苷酸序列的第一数据库与包括表达的多核苷酸序列的第二数据库; 和（b）从第二数据库鉴定表达的多核苷酸序列能够与第一数据库的至少一个有义向多核苷酸序列形成双链体，从而鉴定推定的天然存在的反义转录物。 还提供了通过上述方法鉴定的多核苷酸和多肽序列。
-
39.发明申请Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby 审中-公开通过种间序列比较和生物分子序列鉴定推定基因产物的方法公开(公告)号：US20070082337A1
公开(公告)日：2007-04-12
申请号：US11043591
申请日：2005-01-27
申请人： Rotem Sorek , Sarah Pollock , Alex Diber , Zurit Levine , Sergey Nemzer , Guy Kol , Assaf Wool , Ami Haviv , Yuval Cohen , Yossi Cohen , Ronen Shemesh , Kinneret Savitsky
发明人： Rotem Sorek , Sarah Pollock , Alex Diber , Zurit Levine , Sergey Nemzer , Guy Kol , Assaf Wool , Ami Haviv , Yuval Cohen , Yossi Cohen , Ronen Shemesh , Kinneret Savitsky
CPC分类号： G16B30/00
摘要： A method of identifying alternatively spliced exons is provided. The method comprising, scoring each of a plurality of exon sequences derived from genes of a species according to at least one sequence parameter, wherein exon sequences of the plurality of exon sequences scoring above a predetermined threshold represent alternatively spliced exons, thereby identifying the alternatively spliced exons.
摘要翻译： 提供了一种识别可变剪接外显子的方法。 所述方法包括：根据至少一个序列参数对来自物种基因的多个外显子序列中的每一个进行评分，其中得分高于预定阈值的多个外显子序列的外显子序列代表可变剪接的外显子，由此鉴定可变剪接 外显子
-
40.发明申请Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer 审中-公开新型核苷酸和氨基酸序列，以及其用于诊断前列腺癌的测定和方法公开(公告)号：US20080014590A1
公开(公告)日：2008-01-17
申请号：US11812518
申请日：2007-06-19
申请人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotern Sorek , Michal Avalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
发明人： Dvir Dahary , Sarah Pollock , Zurit Levine , Rotern Sorek , Michal Avalon-Soffer , Pinchas Akiva , Amir Toporik , Osnat Sella-Tavor , Shirley Sameah-Greenwald
IPC分类号： G01N33/574 , C07H21/04 , C07K14/82 , C07K16/30 , C12Q1/68
摘要： Novel markers for prostate cancer that are both sensitive and accurate. Furthermore, these markers are able to distinguish between prostate cancer and benign prostate hyperplasia (“BPH”). These markers are overexpressed in prostate cancer specifically, as opposed to normal prostate tissue and/or BPH. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of prostate cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between prostate cancer and non-cancerous states.
摘要翻译： 前列腺癌的新型标记既灵敏又准确。 此外，这些标记能够区分前列腺癌和良性前列腺增生（“BPH”）。 与正常的前列腺组织和/或BPH相反，这些标记物在前列腺癌中过度表达。 这些标记物在患者样品中单独或组合的测量提供了诊断者可以与前列腺癌的可能诊断相关的信息。 本发明的标记物单独或组合显示前列腺癌与非癌状态之间的高度差异检测。
-
-
-
-
-
-
-
-
-
搜索结果
51 条记录 (耗时 0.098 秒)
